Evidence map›Paper›PMID 24348868›Full record

ArticleNano LIFE2010

MAGNETIC NANOPARTICLE HYPERTHERMIA IN CANCER TREATMENT.

Andrew J Giustini, Alicia A Petryk, Shiraz M Cassim, Jennifer A Tate, Ian Baker, P Jack Hoopes

Abstract read
In one paragraph

Article in Nano LIFE, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Evaluation of Antiproliferative Properties of CoMnZn-FePharmaceuticals (Basel, Switzerland) · 2024
    Article
  12. Review
  13. Recent nanotheranostic approaches in cancer research.Clinical and experimental medicine · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Toxics · 2023
    Review
  20. Review

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Andrew J GiustiniDartmouth Medical School and the Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire 03755, USA, andrew.j.giustini@dartmouth.edu.
Alicia A PetrykThayer School of Engineering, Dartmouth College, Hanover, New Hampshire 03755, USA.
Shiraz M CassimThayer School of Engineering, Dartmouth College, Hanover, New Hampshire 03755, USA.
Jennifer A TateThayer School of Engineering, Dartmouth College, Hanover, New Hampshire 03755, USA.
Ian BakerThayer School of Engineering, Dartmouth College, Hanover, New Hampshire 03755, USA.
P Jack HoopesDartmouth Medical School and the Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire 03755, USA.

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Steven D Leach · 1985 to 2026
$91.3M
Toxicology, Pathology and Biodistribution Core (TPB Core)U54CA151662 · NCI · DARTMOUTH COLLEGE · PI DEMIDENKO, EUGENE · 2010 to 2014
$11.6M
NCI NIH HHS P30 CA023108NCI NIH HHS U54 CA151662
6 · The paper itself

Abstract

The activation of magnetic nanoparticles (mNPs) by an alternating magnetic field (AMF) is currently being explored as technique for targeted therapeutic heating of tumors. Various types of superparamagnetic and ferromagnetic particles, with different coatings and targeting agents, allow for tumor site and type specificity. Magnetic nanoparticle hyperthermia is also being studied as an adjuvant to conventional chemotherapy and radiation therapy. This review provides an introduction to some of the relevant biology and materials science involved in the technical development and current and future use of mNP hyperthermia as clinical cancer therapy.

Indexed as

cancerhyperthermiaMagnetic nanoparticletumor

Identifiers

PMID24348868
PMCPMC3859910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.